"The objective of this study is to report the long-term outcome of a phase II trial of immune-modulatory in situ gene therapy (GT) in combination with intensity-modulated radiotherapy (IMRT) with or without hormonal therapy for the treatment of prostate cancer."
Here is the link to the abstract of the study....
link.springer.com/article/10.1007%2Fs13566-015-0239-y